Ashland
About: Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
Employees: 3,200
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
3.96% more ownership
Funds ownership: 90.47% [Q3] → 94.43% (+3.96%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]
5% less repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 126
7% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 57
4% less funds holding
Funds holding: 364 [Q3] → 351 (-13) [Q4]
17% less capital invested
Capital invested by funds: $3.84B [Q3] → $3.18B (-$661M) [Q4]
62% less call options, than puts
Call options by funds: $2.81M | Put options by funds: $7.38M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
JP Morgan Jeffrey Zekauskas 40% 1-year accuracy 19 / 47 met price target | 5%upside $68 | Neutral Maintained | 30 Jan 2025 |
Wells Fargo Michael Sison 32% 1-year accuracy 14 / 44 met price target | 23%upside $80 | Overweight Maintained | 30 Jan 2025 |
UBS Joshua Spector 45% 1-year accuracy 17 / 38 met price target | 43%upside $93 | Buy Maintained | 29 Jan 2025 |
BMO Capital John McNulty 51% 1-year accuracy 25 / 49 met price target | 29%upside $84 | Market Perform Maintained | 11 Dec 2024 |
Financial journalist opinion
Based on 9 articles about ASH published over the past 30 days
